The DOI matches its Crossref record; 40 of the 41 references it cites were found in a registry or an index.
Tenascin-X Haploinsufficiency Associated with Ehlers-Danlos Syndrome in Patients with Congenital Adrenal Hyperplasia
Open accessAbstract
CONTEXT: The gene for congenital adrenal hyperplasia (CAH) due to 21-hydroxylase deficiency, CYP21A2, is flanked by the gene encoding tenascin-X (TNXB), a connective tissue extracellular matrix protein that has been linked to both autosomal dominant and autosomal recessive Ehlers-Danlos syndrome (EDS). A contiguous deletion of CYP21A2 and TNXB has been described. OBJECTIVE: The objective of the study was to determine the frequency and clinical significance of TNXB haploinsufficiency in CAH patients. DESIGN, SETTING, AND PARTICIPANTS: A total of 192 consecutive unrelated CAH patients being seen as part of an observational study at the National Institutes of Health Clinical Center (Bethesda, MD) were prospectively studied during 2006-2010. Patients were evaluated for clinical evidence of EDS, including cardiac evaluation. DNA was analyzed by PCR, multiplex ligation-dependent probe amplification, Southern blot, and TNXB sequencing. Tenascin-X expression was evaluated by Western blot analysis of fibroblasts and immunostaining of the skin. CAH patients with TNXB haploinsufficiency were compared with age-matched CAH patients with normal TNXB (controls). Phenotyping of 7 parents with TNXB haploinsufficiency was performed. MAIN OUTCOME MEASURES: The frequency of TNXB haploinsufficiency among CAH patients and the frequency of EDS symptomatology among CAH patients with TNXB haploinsufficiency and controls. RESULTS: TNXB haploinsufficiency, here termed CAH-X syndrome, was present in 7% of CAH patients. Twelve of 91 patients carrying a CYP21A2 deletion (13%) carried a contiguous deletion that extended into TNXB. One patient carried a TNXB premature stop codon. Twelve of 13 patients with CAH-X had EDS clinical features. Patients with CAH-X were more likely than age-matched controls to have joint hypermobility (P < .001), chronic joint pain (P = .003), multiple joint dislocations (P = .004), a structural cardiac valve abnormality by echocardiography (P = .02), and reduced tenascin-X expression by Western blot and immunostaining. A subset of parents had clinical findings. CONCLUSIONS: Clinical evaluation for connective tissue dysplasia should be routinely performed in CAH patients, especially those harboring a CYP21A2 deletion.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“CAH-X syndrome is estimated to be found in approximately 7–9% of CAH patients [7, 14, 34] and is classified into three types (CAH-X CH-1, CAH-X CH-2, and CAH-X CH-3) as a result of chimeric recombination events between the TNXB/TNXA during meiosis, resulting in the deletion of the CYP21A2 gene [15].”
From Salt-wasting congenital adrenal hyperplasia phenotype as a result of the TNXA/TNXB chimera 1 (CAH-X CH-1) and the pathogenic IVS2-13A/C > G in CYP21A2 gene (2023) · cites this paper as [14]
In the citing paper
“Interestingly, there have also been reports of heterozygous TNXB gene mutations causing tenascin-X haploinsufficiency, which also results in the signs and symptoms of hypermobile-type EDS [14, 19, 20].”
From Salt-wasting congenital adrenal hyperplasia phenotype as a result of the TNXA/TNXB chimera 1 (CAH-X CH-1) and the pathogenic IVS2-13A/C > G in CYP21A2 gene (2023) · cites this paper as [14]
In the citing paper
“Deletions account for approximately 20% of mutant alleles in 21OHD (189,(195)(196)(197)(198)(199)(200)(201)(202)(203)(204)(205)(206)(207)(208)(209)(210)(211)(212)(213).”
From Congenital Adrenal Hyperplasia—Current Insights in Pathophysiology, Diagnostics, and Management (2022) · cites this paper as [189]
In the citing paper
“Occasionally a breakpoint occurs in the TNX genes, leading to complete deletion of C4B and CYP21A2, and a TNXB/TNXA chimeric gene (149,150,189).”
From Congenital Adrenal Hyperplasia—Current Insights in Pathophysiology, Diagnostics, and Management (2022) · cites this paper as [189]
In the citing paper
“Deletions, the splice site mutation in intron 2 (c.293-13A/C>G) and p.Ile172Asn (I172N) are the most common mutations in most populations (189,195-213).”
From Congenital Adrenal Hyperplasia—Current Insights in Pathophysiology, Diagnostics, and Management (2022) · cites this paper as [189]
11 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Zoghbi, W. A., Enriquez-Sarano, M., Foster, E., Grayburn, P. A., Kraft, C. D., Levine, R. A., Nihoyannopoulos, P., Otto, C. M., Quinones, M. A., Rakowski, H., et al. (2003) · Journal of the American Society of Echocardiography · doi:10.1016/s0894-7317(03)00335-3 · Cited by 4,044
Speiser, P. W., Azziz, R., Baskin, L. S., Ghizzoni, L., Hensle, T. W., Merke, D. P., Meyer-Bahlburg, H. F. L., Miller, W. L., Montori, V. M., Oberfield, S. E., et al. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-2631 · Cited by 1,468
Self-citationSpeiser, P. W., Arlt, W., Auchus, R. J., Baskin, L. S., Conway, G. S., Merke, D. P., Meyer-Bahlburg, H. F. L., Miller, W. L., Murad, M. H., Oberfield, S. E., et al. (2018) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2018-01865 · Cited by 1,234
Self-citation(2000) · PubMed · Cited by 738
Congenital adrenal hyperplasia.
Merke, D. P., & Bornstein, S. R. (2005) · The Lancet · doi:10.1016/s0140-6736(05)66736-0 · Cited by 628
Self-citationHigh frequency of nonclassical steroid 21-hydroxylase deficiency
SPEISER, P. W., DUPONT, B. O., RUBINSTEIN, P., PIAZZA, A., KASTELAN, A., & NEW, M. I. (1986) · Obstetrical & Gynecological Survey · doi:10.1097/00006254-198604000-00017 · Cited by 523
Health status of adults with congenital adrenal hyperplasia: a cohort study of 203 patients
Arlt, W., Willis, D. S., Wild, S. H., Krone, N., Doherty, E. J., Hahner, S., Han, T. S., Carroll, P. V., Conway, G. S., Rees, D. A., et al. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-0917 · Cited by 506
A recessive form of the Ehlers-Danlos syndrome caused by tenascin-X deficiency
Schalkwijk, J., Zweers, M. C., Steijlen, P. M., Dean, W. B., Taylor, G., van Vlijmen, I. M., van Haren, B., Miller, W. L., & Bristow, J. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa002939 · Cited by 391
High frequency of nonclassical steroid 21-hydroxylase deficiency.
Speiser, P., Dupont, B., Rubinstein, P., Piazza, A., Kaštelan, A., & New, M. I. (1985) · PubMed · Cited by 374
Tenascin-X deficiency is associated with Ehlers-Danlos syndrome
Burch, G. H., Gong, Y., Liu, W., Dettman, R. W., Curry, C. J., Smith, L., Miller, W. L., & Bristow, J. (1997) · Nature Genetics · doi:10.1038/ng0997-104 · Cited by 366
Cited by
Congenital adrenal hyperplasia
El-Maouche, D., Arlt, W., & Merke, D. P. (2017) · The Lancet · doi:10.1016/s0140-6736(17)31431-9 · Cited by 669
Self-citationCongenital Adrenal Hyperplasia—Current Insights in Pathophysiology, Diagnostics, and Management
Claahsen - van der Grinten, H. L., Speiser, P. W., Ahmed, S. F., Arlt, W., Auchus, R. J., Falhammar, H., Flück, C. E., Guasti, L., Huebner, A., Kortmann, B. B. M., et al. (2022) · Endocrine Reviews · doi:10.1210/endrev/bnab016 · Cited by 556
Self-citationTinkle, B., Castori, M., Berglund, B., Cohen, H., Grahame, R., Kazkaz, H., & Levy, H. (2017) · American Journal of Medical Genetics Part C: Seminars in Medical Genetics · doi:10.1002/ajmg.c.31538 · Cited by 499
Congenital adrenal hyperplasia due to 21-hydroxylase deficiency
Merke, D. P., & Auchus, R. J. (2020) · New England Journal of Medicine · doi:10.1056/nejmra1909786 · Cited by 341
Self-citationMalfait, F., Castori, M., Francomano, C. A., Giunta, C., Kosho, T., & Byers, P. H. (2020) · Nature Reviews Disease Primers · doi:10.1038/s41572-020-0194-9 · Cited by 316
Genetics of congenital adrenal hyperplasia
Krone, N., & Arlt, W. (2009) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2008.10.014 · Cited by 312
The Ehlers–Danlos syndromes, rare types
Brady, A. F., Demirdas, S., Fournel‐Gigleux, S., Ghali, N., Giunta, C., Kapferer‐Seebacher, I., Kosho, T., Mendoza‐Londono, R., Pope, M. F., Rohrbach, M., et al. (2017) · American Journal of Medical Genetics Part C Seminars in Medical Genetics · doi:10.1002/ajmg.c.31550 · Cited by 258
Management of adolescents with congenital adrenal hyperplasia
Merke, D. P., & Poppas, D. P. (2013) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(13)70138-4 · Cited by 134
Self-citationTenascin-X: beyond the architectural function
Valcourt, U., Alcaraz, L. B., Exposito, J.-Y., Lethias, C., & Bartholin, L. (2015) · Cell Adhesion & Migration · doi:10.4161/19336918.2014.994893 · Cited by 132
Colombi, M., Dordoni, C., Chiarelli, N., & Ritelli, M. (2015) · American Journal of Medical Genetics Part C: Seminars in Medical Genetics · doi:10.1002/ajmg.c.31429 · Cited by 127
Genetics of Congenital Adrenal Hyperplasia
Hannah-Shmouni, F., Chen, W., & Merke, D. P. (2017) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2017.01.008 · Cited by 97
Self-citationChiarelli, N., Ritelli, M., Zoppi, N., & Colombi, M. (2019) · Genes · doi:10.3390/genes10080609 · Cited by 82
Broadening the Spectrum of Ehlers Danlos Syndrome in Patients With Congenital Adrenal Hyperplasia
Morissette, R., Chen, W., Perritt, A. F., Dreiling, J. L., Arai, A. E., Sachdev, V., Hannoush, H., Mallappa, A., Xu, Z., McDonnell, N. B., et al. (2015) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2015-2232 · Cited by 68
“prevalence relative to our previous report (8) in a large”
BackgroundMethodResultSelf-citationComprehensive Mutation Analysis of the CYP21A2 Gene
Xu, Z., Chen, W., Merke, D. P., & McDonnell, N. B. (2013) · The Journal of Molecular Diagnostics · doi:10.1016/j.jmoldx.2013.06.001 · Cited by 62
Self-citationTenascin-X, Congenital Adrenal Hyperplasia, and the CAH-X Syndrome
Miller, W. L., & Merke, D. P. (2018) · Hormone Research in Paediatrics · doi:10.1159/000481911 · Cited by 61
Self-citationDemirdas, S., Dulfer, E., Robert, L., Kempers, M., van Beek, D., Micha, D., van Engelen, B. G., Hamel, B., Schalkwijk, J., Loeys, B., et al. (2017) · Clinical Genetics · doi:10.1111/cge.12853 · Cited by 60
Baronio, F., Ortolano, R., Menabò, S., Cassio, A., Baldazzi, L., Natale, V. D., Tonti, G., Vestrucci, B., & Balsamo, A. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20184605 · Cited by 60
Matricellular Proteins in the Trabecular Meshwork: Review and Update
Chatterjee, A., Villarreal, G., & Rhee, D. J. (2014) · Journal of Ocular Pharmacology and Therapeutics · doi:10.1089/jop.2014.0013 · Cited by 50
Wang, R., Yu, Y., Ye, J., Han, L., Qiu, W., Zhang, H., Liang, L., Gong, Z., Wang, L., & Gu, X. (2016) · Steroids · doi:10.1016/j.steroids.2016.01.007 · Cited by 52
Chen, W., Perritt, A. F., Morissette, R., Dreiling, J. L., Bohn, M.-F., Mallappa, A., Xu, Z., Quezado, M., & Merke, D. P. (2016) · Human Mutation · doi:10.1002/humu.23028 · Cited by 45
Self-citationGenes and Pseudogenes: Complexity of the RCCX Locus and Disease
Carrozza, C., Foca, L., De Paolis, E., & Concolino, P. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.709758 · Cited by 37
Updates in Clinical and Genetics Aspects of Hypermobile Ehlers Danlos Syndrome
Forghani, I. (2018) · Balkan Medical Journal · doi:10.4274/balkanmedj.2018.1113 · Cited by 40
Gao, Y., Lu, L., Yu, B., Mao, J., Wang, X., Nie, M., & Wu, X. (2020) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaa199 · Cited by 31
Joint Hypermobility and Headache: Understanding the Glue That Binds the Two Together – Part 1
Neilson, D., & Martin, V. T. (2014) · Headache The Journal of Head and Face Pain · doi:10.1111/head.12418 · Cited by 34
Lao, Q., Brookner, B., & Merke, D. P. (2019) · The Journal of Molecular Diagnostics · doi:10.1016/j.jmoldx.2019.06.001 · Cited by 29
Self-citationTenascin-X—Discovery and Early Research
Miller, W. L. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2020.612497 · Cited by 26
Extracellular Matrix Remodeling During Palate Development
Wang, X., Li, C., Zhu, Z., Yuan, L., Chan, W. Y., & Sha, O. (2020) · Organogenesis · doi:10.1080/15476278.2020.1735239 · Cited by 26
Marino, R., Garrido, N. P., Ramirez, P., Notaristéfano, G., Moresco, A., Touzon, M. S., Vaiani, E., Finkielstain, G., Obregón, M. G., Balbi, V., et al. (2021) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgab033 · Cited by 23
Multiple Roles of Tenascins in Homeostasis and Pathophysiology of Aorta
Imanaka‐Yoshida, K., & Matsumoto, K. (2018) · Annals of Vascular Diseases · doi:10.3400/avd.ra.17-00118 · Cited by 22
Morissette, R., Merke, D. P., & McDonnell, N. B. (2014) · European Journal of Medical Genetics · doi:10.1016/j.ejmg.2013.12.004 · Cited by 27
Self-citationScicluna, K., Formosa, M. M., Farrugia, R., & Borg, I. (2022) · Clinical Genetics · doi:10.1111/cge.14026 · Cited by 20
Yang, M., & White, P. C. (2025) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgae535 · Cited by 20
“However, up to 14% of patients with CAH have heterozygous TNXB mutations (95).”
Congenital Adrenal Hyperplasia and Ehlers-Danlos Syndrome
Marino, R. M., Moresco, A., Garrido, N. P., Ramírez, P., & Belgorosky, A. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.803226 · Cited by 23
Lao, Q., & Merke, D. P. (2021) · European Journal of Human Genetics · doi:10.1038/s41431-021-00870-5 · Cited by 23
Self-citationNovel TNXB Variants in Two Italian Patients with Classical-Like Ehlers-Danlos Syndrome
Micale, L., Guarnieri, V., Augello, B., Palumbo, O., Agolini, E., Sofia, V. M., Mazza, T., Novelli, A., Carella, M., & Castori, M. (2019) · Genes · doi:10.3390/genes10120967 · Cited by 23
Kim, J. H., Kim, G.-H., Yoo, H., & Choi, J. (2023) · Annals of Pediatric Endocrinology & Metabolism · doi:10.6065/apem.2346108.054 · Cited by 20
An overview of inborn errors of metabolism manifesting with primary adrenal insufficiency
Hannah‐Shmouni, F., & Stratakis, C. A. (2018) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-018-9447-2 · Cited by 18
Lao, Q., Mallappa, A., Faucz, F. R., Joyal, E., Veeraraghavan, P., Chen, W., & Merke, D. P. (2020) · Molecular Genetics & Genomic Medicine · doi:10.1002/mgg3.1556 · Cited by 17
Self-citationEhlers-Danlos Syndromes, Joint Hypermobility and Hypermobility Spectrum Disorders
Micale, L., Fusco, C., & Castori, M. (2021) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-80614-9_9 · Cited by 21
Paragliola, R. M., Perrucci, A., Foca, L., Urbani, A., & Concolino, P. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11133818 · Cited by 17
Long-Read Sequencing Solves Complex Structure of CYP21A2 in a Large 21-Hydroxylase Deficiency Cohort
Wang, R., Luo, X., Sun, Y., Liang, L., Mao, A., Lu, D., Zhang, K., Yang, Y., Sun, Y., Sun, M., et al. (2024) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgae519 · Cited by 16
CAH-X Syndrome: Genetic and Clinical Profile
Concolino, P., & Falhammar, H. (2022) · Molecular Diagnosis & Therapy · doi:10.1007/s40291-022-00588-0 · Cited by 19
Paragliola, R. M., Perrucci, A., Foca, L., Urbani, A., & Concolino, P. (2022) · doi:10.20944/preprints202206.0329.v1 · Cited by 13
Lao, Q., Jardin, M. D., Jayakrishnan, R., Ernst, M., & Merke, D. P. (2018) · Human Genetics · doi:10.1007/s00439-018-1959-z · Cited by 12
Self-citationConcolino, P., & Falhammar, H. (2025) · Journal of the Endocrine Society · doi:10.1210/jendso/bvaf018 · Cited by 12
Wang, Y., Zhu, G., Li, D., Pan, Y., Li, R., Zhou, T., Mao, A., Chen, L., Zhu, J., & Zhu, M. (2025) · Human Genomics · doi:10.1186/s40246-024-00696-4 · Cited by 12
Zhang, R., Cui, D., Song, C., Ma, X., Cai, N., Zhang, Y., Feng, M., Cao, Y., Chen, L., & Qiang, R. (2024) · Clinica Chimica Acta · doi:10.1016/j.cca.2024.117820 · Cited by 13
Jayakrishnan, R., Lao, Q., Adams, S. D., Ward, W. W., & Merke, D. P. (2018) · Gene · doi:10.1016/j.gene.2018.11.023 · Cited by 10
Self-citationJoint Hypermobility Syndrome and Membrane Proteins: A Comprehensive Review
Pliego-Arreaga, R., Cervantes‐Montelongo, J. A., Silva-Martínez, G. A., Tristán-Flores, F. E., Pantoja-Hernández, M. Á., & Maldonado-Coronado, J. R. (2024) · Biomolecules · doi:10.3390/biom14040472 · Cited by 9
Copy Number Variations in Genetic Diagnosis of Congenital Adrenal Hyperplasia Children
Tolba, A., Mandour, I., Musa, N., Elmougy, F., Hafez, M., Abdelatty, S., Ibrahim, A., Soliman, H., Labib, B., Elshiwy, Y., et al. (2022) · Frontiers in Genetics · doi:10.3389/fgene.2022.785570 · Cited by 8
Kolli, V., Kim, H., Rao, H., Lao, Q., Gaynor, A., Milner, J. D., & Merke, D. P. (2019) · BMC Research Notes · doi:10.1186/s13104-019-4753-7 · Cited by 9
Self-citationLao, Q., Burkardt, D. D., Kollender, S., Faucz, F. R., & Merke, D. P. (2023) · Molecular Genetics & Genomic Medicine · doi:10.1002/mgg3.2195 · Cited by 8
Self-citationLao, Q., Schulman, A., Kulkarni, S., Kollender, S., Bick, D., Moon, A., Burkardt, D. D., & Merke, D. P. (2025) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaf546 · Cited by 6
Self-citationBaumgartner-Parzer, S. M., Witsch‐Baumgartner, M., & Hoeppner, W. (2021) · European Journal of Human Genetics · doi:10.1038/s41431-021-00869-y · Cited by 5
Fanis, P., Skordis, N., Phylactou, L. A., & Neocleous, V. (2023) · HORMONES · doi:10.1007/s42000-022-00410-w · Cited by 4
“The father of the neonate who was a carrier of the chimeric TNXA/TNXB (CAH-X CH-1) genotype also did not present any clinical manifestations of EDS.”
BackgroundInfluentialAbalı, Z. Y., Yıldız, M., Abalı, S., Moniri, A., Baş, F., Önal, H., Çilsaat, G., Toksoy, G., Turan, S., Poyrazoğlu, Ş., et al. (2025) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaf612 · Cited by 5
Genomic complexity and clinical significance of the RCCX locus
Shiryagin, V. V., Deviatkin, A. A., Fateev, O. D., Petriaikina, E. S., Bogdanov, V. P., Antysheva, Z., Volchkov, P., Yudin, S. M., Woroncow, M. V., & Skvortsova, V. I. (2024) · PeerJ · doi:10.7717/peerj.18243 · Cited by 3
Qiu, C., Li, Y., Gong, Y., Sherman, W., Tian, D., Lin, W., Pan, Z., Afolabi, B., Thumbigere‐Math, V., Su, K.-J., et al. (2026) · Bone Research · doi:10.1038/s41413-026-00520-w · Cited by 4
Pseudogene TNXA Variants May Interfere with the Genetic Testing of CAH-X
Lao, Q., Zhou, K., Parker, M., Faucz, F. R., & Merke, D. P. (2023) · Genes · doi:10.3390/genes14020265 · Cited by 1
“However, in general, CAH patients suffer more connective tissue dysplasia phenotype than their carrier counterparts, possibly due to the influence of chronic glucocorticoid exposure [7,8,11,28].”
BackgroundMethodInfluentialSelf-citationRadler, C. N., Wang, T., LeGate, J. F., Crone, L., Deo, P., Wortley, J., Moore, P., Bryant, G., Smitherman, K., & Sathyamoorthy, M. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26136535 · Cited by 2
The Principles, Enzymes, and Pathways of Human Steroidogenesis
Auchus, R. J., & Miller, W. L. (2015) · Elsevier eBooks · doi:10.1016/b978-0-323-18907-1.00097-4 · Cited by 3
Molecular Genetics of 21‐Hydroxylase Deficiency
Parajes, S., & Krone, N. P. (2014) · Wiley eBooks · doi:10.1002/9780470015902.a0023845 · Cited by 2
Monlong, J., Chen, X., Barseghyan, H., Rowell, W. J., Negi, S., Nokoff, N., Mohnach, L. H., Hirsch, J. A., Finlayson, C. A., Keegan, C. E., et al. (2025) · medRxiv · doi:10.1101/2025.02.07.25321404 · Cited by 3
Pignatelli, D., & Pereira, S. S. (2021) · Springer eBooks · doi:10.1007/978-3-030-82591-1_2 · Cited by 1
Die Ehlers-Danlos-Syndrome mit Schwerpunkt auf dem hypermobilen Typ: Literaturreview und Update
Sturm, K., & Bohn, M. (2019) · Journal für Mineralstoffwechsel & Muskuloskelettale Erkrankungen · doi:10.1007/s41970-019-0058-5 · Cited by 1
Figueras, L. M., Muñoz‐Pacheco, R., González, D. G., Arriba, M., & Zubicaray, B. E. (2023) · Advances in Laboratory Medicine / Avances en Medicina de Laboratorio · doi:10.1515/almed-2023-0050 · Cited by 2
Chong, H., Xue, G., Pi, Y., Zhang, Y., Li, Y., Xing, Y., Chen, B., & Zhang, H. (2025) · Frontiers in Endocrinology · doi:10.3389/fendo.2025.1665306 · Cited by 3
Figueras, L. M., Muñoz‐Pacheco, R., González, D. G., Arriba, M., & Zubicaray, B. E. (2023) · Advances in Laboratory Medicine / Avances en Medicina de Laboratorio · doi:10.1515/almed-2023-0071 · Cited by 4
Ivo, C. R., Fitas, A. L., Madureira, I., Diamantino, C., Gomes, S., Gonçalves, J., & Lopes, L. (2022) · Journal of Pediatric Endocrinology and Metabolism · doi:10.1515/jpem-2022-0396 · Cited by 1
Tenascin-X gene defects and cardiovascular disease
Morissette, R., McDonnell, N. B., & Merke, D. P. (2014) · Medical Hypotheses · doi:10.1016/j.mehy.2014.01.027 · Cited by 1
Self-citationDiagnosing CAH-X syndrome by long-read sequencing and identifying a novel genotype
Li, Z., Xu, S., Fu, Q., Du, L., Lin, Q., Lin, H., E., H., & Liu, H. (2026) · Orphanet Journal of Rare Diseases · doi:10.1186/s13023-026-04356-9
Baumgartner-Parzer, S. M., & Schernthaner-Reiter, M. H. (2021) · Journal für Klinische Endokrinologie und Stoffwechsel · doi:10.1007/s41969-021-00150-z
Finkielstain, G. P., Jha, S., & Merke, D. P. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-817962-8.00008-1 · Cited by 1
Self-citationZhu, F., Li, Y., Wang, Y., Yao, Y., & Zeng, R. (2023) · Frontiers in Genetics · doi:10.3389/fgene.2023.1180149
Chen, X., Zhao, J., Li, D., Na, X., Yi, D., Yan, M., Yin, Y., & Wang, X. (2024) · Molecular Genetics & Genomic Medicine · doi:10.1002/mgg3.70029
Aynacı, S., Kocagil, S., & Çilingir, O. (2026) · Molecular Syndromology · doi:10.1159/000552325
Novel cardiac abnormalities observed in CAH patients with tenascin-X haploinsufficiency
Sappl, A., Sriramachandran, A. M., Lottspeich, C., Vill, K., Morak, M., Welp, A.-C., Dervishi, O., Bidlingmaier, M., Kunz, S. L., & Reisch, N. (2026) · Frontiers in Endocrinology · doi:10.3389/fendo.2026.1797669
Imanaka, B., Hasegawa, Y., Kawato, K., Kimoto, Y., Oda, I., Okamoto, N., Saigoh, K., & Nakama, M. (2026) · Biochemical Genetics · doi:10.1007/s10528-026-11416-z
The evolution of new approaches to the treatment of congenital adrenal hyperplasia
Merke, D. P., & Auchus, R. J. (2026) · Endocrine Reviews · doi:10.1210/endrev/bnag033
Self-citationXia, Y., Cui, D., Li, D., Chen, L., Chen, X., Wu, S., Mao, A., & Kong, X. (2026) · Journal of Molecular Diagnostics · doi:10.1016/j.jmoldx.2026.08.004
Management of congenital adrenal hyperplasia due to 21-hydroxylase deficiency: an update
Bobrowicz, M., Roszkowska, Z., Domański, J., Ginalska-Malinowska, M., Rak, B., Gastoł, P., Betlejewska, J., Gładka, A., Hubska, J., & Ambroziak, U. (2026) · Endokrynologia Polska · doi:10.5603/ep.110211
Kablan, A., Baştan, F., Tezcan, A. Y., Bölükbaşı, A., Erdeve, Ş. S., & Erdem, H. B. (2026) · Gazi Medical Journal · doi:10.12996/gmj.2026.4747
Tenascin X and Tenascin C Serum Levels in Relation to Age and Cardiometabolic Risk Parameters
Baumgartner-Parzer, S. M., Fuhrberg, K., Wagenlechner, C., Schnait, F., Schmid, N., Bayerle‐Eder, M., Grimm, G., Vila, G., & Schernthaner-Reiter, M. H. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27209180
Metadata
- Authors
- Merke, D. P., Chen, W., Morissette, R., Xu, Z., Van Ryzin, C., Sachdev, V., Hannoush, H., Shanbhag, S. M., Acevedo, A. T., Nishitani, M., Arai, A. E., & McDonnell, N. B.
- Affiliations
- National Institutes of Health (US)
- National Institute on Aging (US)
- National Heart, Lung, and Blood Institute (US)
- National Institutes of Health Clinical Center (US)
- Corresponding author
- Merke, Deborah P.
- ORCID
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2013-02
- Volume
- 98
- Issue
- 2
- Pages
- E379-E387
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- PMC
- PMC3565116
- OpenAlex
- W2010913631
- Cited by
- 82
- References
- 41
- Citations by year
- 2026: 9 · 2025: 8 · 2024: 5 · 2023: 6 · 2022: 6 · 2021: 11 · 2020: 6 · 2019: 6 · 2018: 6 · 2017: 4 · 2016: 3 · 2015: 4 · 2014: 5 · 2013: 2
- FWCI
- 2.09
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- CARES Foundation
- Ohio State University
- National Institutes of Health
- U.S. Public Health Service
- National Institute on Aging
- National Heart, Lung, and Blood Institute
- National Institute of Child Health and Human Development
- Eunice Kennedy Shriver National Institute of Child Health and Human Development
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Sexual Differentiation and Disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Connective tissue disorders research
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Keywords
- tenascin-X, congenital adrenal hyperplasia, 21-hydroxylase deficiency, CYP21A2, Ehlers-Danlos syndrome, contiguous gene deletion, connective tissue dysplasia, joint hypermobility, premature stop codon
- MeSH terms
- Adolescent, Adrenal Hyperplasia, Congenital, Adult, Aged, Child, Child, Preschool, Joint Dislocations, Ehlers-Danlos Syndrome, Female, Humans, Infant, Joint Instability, Male, Middle Aged, Mutation, Pain, Steroid 21-Hydroxylase, Tenascin, Haploinsufficiency
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.